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XNA ligation using T4 DNA ligase in crowding conditions 
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T4 DNA ligase is capable of ligating 2’OMe-RNA duplexes, 
HNA, LNA and FANA mixed sequences in the presence of 10% 
w/v PEG8000 and 3 M betaine. The enzymatic joining of 
oligonucleotides containing multiple consecutive XNA 
nucleotides at the ligation site has not been reported before. 
Backbone-modified nucleic acids are often enzymatically and 
chemically more stable than DNA and RNA, making them 
relevant in diagnostics or therapeutics as probes, aptamers, 
aptazymes, siRNAs or antisense RNAs,
1-5
 as orthogonal genetic 
materials for the development of safe genetically contained 
organisms (or ‘GCOs’),
6, 7
 or in nanotechnology.
8, 9
  
It is a significant technical challenge to synthesise a backbone-
modified nucleic acid or an oligonucleotide with a diversity of 
backbone chemistries. DNA-dependent xeno nucleic acid 
(XNA) polymerases have been engineered and XNA synthesis is 
possible.
1
 Nonetheless, the enzymes are not processive and 
can introduce errors during synthesis.
10
 Some backbone-
modified nucleic acids can be chemically synthesised, but the 
length of the modified fragments is often limited due to the 
lower coupling efficiency of the monomer phosphoramidites 
and between different chemistries on solid-phase, and for 
some chemistries, no solid-phase synthesis method is 
available.  
The problems associated with the synthesis of longer, mixed-
chemistry nucleic acid fragments, could be circumvented by 
using ligases to join shorter pieces of modified nucleic acids. 
This strategy has been used for the generation of highly 
functionalized base-modified DNA aptamers.
11, 12
 T4 DNA 
ligase catalyses the phosphodiester bond formation between 
the 3′-hydroxyl group (‘acceptor’) and the 5′-phosphate 
terminus (‘donor’) of juxtaposed oligonucleotides in nicked 
DNA or, in some cases, in a hybrid DNA/RNA or RNA duplex.
13-
17
 Additionally, it can join blunt and cohesive ends.
18
 T4 DNA 
ligase has shown to tolerate some mismatches in certain 
conditions,
14, 19-26
 some modified bases
27
 and has recently 
been reported to accept oligonucleotides with single 
backbone-modified nucleotide substitutions as a substrate, 
albeit with reduced efficiency.
28-30
 The enzyme has shown to 
ligate DNA fragments unmodified at the ligation site but 
containing several PNA nucleotides.
31
 
Crowding agents such as high molecular weight PEG, BSA, 
glycogen, Ficoll PM 70 and hexaminecobalt(III) chloride and 
organic solvents such as DMSO and formamide can be used to 
stimulate ligations using T4 DNA ligase, whether enabling 
ligation across mismatches or fine tuning the specificity of 
ligase detection reaction. 
19, 32-40
 Additionally, a number of 
small molecules (MW < 1000 Da) such as 1,2-propanediol, 
ethylene glycol and straight or branched chain alcohols (e.g. 
ethanol and isopropanol) have been patented as potential 
enhancers of T4 DNA ligation activity.
41
  
Despite the effect that additives have shown on the activity of 
T4 DNA ligase, the influence of these factors on the substrate 
spectrum of nucleic acid ligases has not been previously 
explored. We set out to screen a panel of commercially 
available DNA and RNA ligases using crowding conditions and 
cosolutes to test the potential impact on their substrate 
specificity. We focused our screen on the ligation of 2’OMe 
RNA, LNA (‘locked’ nucleic acids), FANA (2’-fluoroarabino 
nucleic acids) and HNA (1,5-dianhydrohexitol nucleic acids) as 
model XNAs as they cover a range of structures in the vicinity 
of both DNA and RNA. An overview of the oligonucleotides is 
given in Table S1.  
In initial experiments used to measure the basal ligase activity 
to join DNA-2’OMe RNA chimeric duplexes, only T3 DNA ligase, 
T4 DNA ligase, T7 DNA ligase and SplintR DNA ligase showed 
ligation activity (Figure 1 left). T4 DNA consistently 
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outperformed other ligases (Figure 1 right) and was selected 
for further optimization.  
  
Figure 1. The ligation of A1 to D2 opposite T1 (left) or A2 to D2 opposite T1 (right) 
overnight with different ligases at the reported optimal temperature for each ligase, 
using 0.1 µM for the acceptor, 0.2 µM for the donor and the template oligonucleotides, 
and 1 µl of commercial enzyme per 10 µl reaction volume. P indicates the primer 
control, A indicates the position of the FAM-labelled acceptor oligonucleotide on the 
gel, whereas AD shows the position of the reaction product. The lanes in the gel 
contain the reaction catalysed by the following ligases: 1. Rhodothermus marinus DNA 
ligase, 2. Thermus scotoductus DNA ligase, 3. Taq DNA ligase, 4. Ampligase, 5. 9°N DNA 
ligase, 6. Thermostable RNA ligase, 7. T4 DNA ligase, 8. T3 DNA ligase, 9. T7 DNA ligase, 
10. E. coli DNA ligase, 11. SplintR DNA ligase, 12. T4 RNA ligase 1, 13. T4 RNA ligase 2 
We screened the impact of molecular crowding agents and co-
solutes on the ligation of 2’OMe RNA molecules (both donor 
and acceptor) against a DNA template, which are poor ligation 
substrates for the enzyme in standard conditions (Figure S1). 
Additionally, 5’ deadenylase was tested because it has been 
reported to increase the ligation yield in reactions where the 
yield is limited due to the abortive formation of 5′-adenylated 
DNA end product. Betaine, PEG8000 and DMSO (Figure 2) had 
the biggest impact in enhancing the ligation, with more than 
50% of the products ligated in the presence of betaine or 
PEG8000 in stark contrast to the non-detectable ligation levels 
in the absence of these enhancers, and were chosen for 
further optimization. DMSO and betaine enhanced the 
reaction even at the highest concentrations tested (40% v/v 
and 3 M respectively), while PEG8000 enhancement was 
optimum at around 10% w/v (See Table S2 for results). This is 
similar to the effect observed with PEG8000 and T7 DNA 
polymerase
42
 and could, likewise, be explained by the 
increased binding of the enzyme to the nicked nucleic acid 
duplex as the PEG8000 concentration increases, together with 
a diminishing catalytic activity, hampering the ligation event at 
higher PEG8000 concentrations. We further optimised the 
reaction to identify the best ratio of the three components. 
Near-complete (>90%) ligation of two 2’OMe-RNA oligos 
against a 2’OMe-RNA template were achieved in 10% 
PEG8000, 3 M betaine, 10 mM Mg
2+
 and 10 μM ATP, in the 
presence of 4 U/μl enzyme and 0.1 µM of acceptor (A2) and 
0.2 µM of the donor (D3) and template (T2) oligonucleotides in 
reactions carried out at 37°C for 16 hours (Figure 3). No 
ligation was observed in standard ligase reaction buffer in 
those conditions.  
Having demonstrated that the PEG8000/betaine 
supplemented buffer enhanced 2’OMe RNA ligation, we set 
out to investigate whether it could be used to enhance ligation 
of a range of XNAs. As shown in Figure 3 and Figure S2, the 
optimized buffer enables ligation of a variety of XNAs in the 
close structural vicinity of DNA and RNA, generating molecules 
whose chemical synthesis (including multiple different 
chemistries) would be challenging. The identity of the ligation 
products was confirmed by mass spectrometry (MS spectra in 
Figure 3) using biotinylated template strands for capture on 
streptavidin magnetic beads and elution of the ligated 
sequences using NaOH prior to the analysis. An alternative 
series of 2’OMe RNA and HNA oligonucleotides was ligated to 
demonstrate that the T4 DNA ligase-catalyzed ligation in these 
conditions is possible in multiple sequence contexts.  
Figure 2. The bar represents the percentage of ligation of A2 to D3 using T1 as a 
template at a 0.1 µM (A2) or 0.2 µM (D3 and T1) concentration using T4 DNA ligase (4 
U/µl concentration final) in the presence of (different concentrations of) the additives. 
The reaction in standard T4 DNA ligase reaction buffer is indicated by ‘T4 LRB’. PrD 
represents 1,2-propanediol, TPAC signifies tetrapropyl ammonium chloride. The 
reactions were incubated at 25°C for 16 hours. All reactions were carried out in 
triplicate.  
In a parallel strategy, we investigated whether the addition of 
DNA binding domains to T4 DNA ligase could also contribute to 
extend its substrate range.
43,44
 Chimeric proteins were 
screened but no significant further reaction enhancement was 
observed (data not shown). 
The activity of the enzyme was measured in a time course 
assay in the presence and absence of 10% PEG8000 and 3 M 
betaine. No increase in enzymatic activity could be observed in 
the presence of the crowding agents. On the contrary, a slight 
decrease in the ligation activity could be observed (Figure S3). 
An increased (and concentration dependent) binding of the 
enzyme to its substrate is observed in the presence of 10 % 
PEG8000, likely enabling the ligation of the unnatural 
substrates (data not shown). 
Conclusions 
Molecular crowding has been previously exploited to increase 
the catalytic activity of nucleic acid processing enzymes. In 
particular, polyethylene glycol (PEG) has been extensively used 
to enhance molecular interactions, including DNA binding 
proteins,
45
 nucleic acid processing enzymes
32-36, 46-49
 and DNA 
polymerases.
42, 50-52
 Similarly, DMSO and betaine have shown a 
positive effect on DNA polymerase reactions, potentially by 
destabilizing unwanted secondary structures in double 
stranded DNA and reducing the base pair composition 
dependency of DNA melting in PCR.
53-55
 Betaine could function 
as a protein stabiliser.
56-59
 It has shown to improve Ligase 
Cycling Reactions (LCR), using a thermostable ligase, in the 
past.
60
 However, it has also proven destabilizing to some 
proteins in certain conditions.
61-64
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Figure 3 The ligation of a 2’OMe RNA duplex and FANA, LNA and HNA chimeras in T4 DNA ligase reaction buffer with or without PEG8000 10% and 3 M betaine, in the optimized 
conditions. The ligation substrates are shown schematically under the figure, where red indicates 2’OMe RNA, yellow FANA, blue HNA and purple LNA. The oligos used were A2-
D3/T2 (2’OMe RNA); A2-D4, A3-D2 and A3-D4/T1 for FANA; A7-D7/T4, A6-D9/T4 and A7-D8/T5, respectively for HNA; and A4-D3, and A2-D6/T1 for LNA. The deconvoluted mass 
spectra of the ligation of a 2’OMe RNA duplex (B, theoretical mass 12041) HNA as either the acceptor (C top, theoretical mass 7894) or as the donor (C bottom, theoretical mass 
8180) in the reaction are shown in the right. 
Here, we show that in crowding conditions T4 DNA ligase can 
function as an XNA ligase for a range of chemistries that have 
already been validated as synthetic genetic materials: 2’OMe 
RNA,
65
 HNA, FANA and LNA.
1
 Mixed chemistry polymers 
cannot be delivered by polymerases, but can be read out by a 
single XNA reverse transcriptase, enabling aptamer/aptazyme 
selections using mixed-chemistry oligomers.
1
 
We observed that T4 DNA ligase accepts 2’OMe RNA and FANA 
much more as a substrate in the acceptor than in the donor 
position – in agreement with findings that T4 DNA ligase 
reaction rate decreases 32,000-fold from a RNA-DNA/DNA 
duplex to a DNA-RNA/DNA hybrid ligation at 37°C
66
 and the 
differential effect of the substitution of a single DNA 
nucleotide by a 2′OMe RNA building block on either side of the 
nick
28
. This effect can be explained by the larger area of 
interaction between the ligase and its substrate on the 5′-end 
of the nick. The contact between T4 DNA ligase and its 
substrate has been determined to be seven to nine bases on 
the donor side of the nick and three to five bases on the 
acceptor side.
67
  
The above findings allow the construction of long XNA or 
mixed chemistry oligonucleotides, which could be useful for 
producing non-toxic origami structures with an enhanced 
stability for in-cell delivery,
8
 circular mRNA, aptamers or 
aptazymes with increased stability and enhanced 
reproducibility of binding due to a decreased tendency to fold 
into alternative secondary structures
68-70
 or for siRNA 
applications. Additionally, in the field of xenobiology, the initial 
ligation of XNA-containing oligonucleotides is an important 
stepping stone towards the in vitro evolution of an XNA ligase 
and paves the way towards XNA applications in vivo (an XNA 
episome for the construction of safe GCOs). Finally, the above 
results show that it may be possible to use the strategy 
presented here to extend the substrate and reaction range of 
other nucleic acid processing enzymes greatly decreasing the 
engineering challenge for the development of XNA molecular 
biology. 
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